[HTML][HTML] Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Low Body Weight Patients with Atrial Fibrillation: A Systematic Review and Meta …
MN Elshafei, M Salem, A El-Bardissy… - … Drugs and Therapy, 2024 - Springer
Introduction Direct oral anticoagulant (DOAC) agents are established as the anticoagulation
strategy of choice for a variety of clinical risks. Despite this, uncertainty still exists with regard …
strategy of choice for a variety of clinical risks. Despite this, uncertainty still exists with regard …
Effectiveness and safety of edoxaban therapy in daily-care patients with atrial fibrillation. Results from the DRESDEN NOAC REGISTRY
C Köhler, L Tittl, S Marten, C Naue, M Spindler… - Thrombosis …, 2022 - Elsevier
Background Edoxaban is a non-vitamin K dependent oral anticoagulant (NOAC) licensed for
stroke prevention in atrial fibrillation (SPAF). Outcome data on clinical effectiveness and …
stroke prevention in atrial fibrillation (SPAF). Outcome data on clinical effectiveness and …
[HTML][HTML] The safety and efficacy of nonvitamin K antagonist oral anticoagulants in morbidly obese patients with atrial fibrillation: a meta-analysis
Background and aim Atrial fibrillation (AF) is the most frequently observed cardiac
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …
arrhythmia in clinical settings. Obesity can influence the efficacy of the treatment …
Safety and efficacy of oral anticoagulants in extreme weights
J Chin-Hon, L Davenport, J Huang, M Akerman… - Thrombosis …, 2023 - Elsevier
Abstract Background The 2021 International Society on Thrombosis and
Haemostasis'(ISTH) recommends standard doses of apixaban and rivaroxaban regardless …
Haemostasis'(ISTH) recommends standard doses of apixaban and rivaroxaban regardless …
Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight.
MIM Danjuma, MN Elshafei… - … Journal of Clinical …, 2022 - search.ebscohost.com
Bodega et al.'s recent report on the efficacy and safety of direct oral anticoagulants (DOACs)
in patients with nonvalvular atrial fibrillation and extreme body weight reinforces recent …
in patients with nonvalvular atrial fibrillation and extreme body weight reinforces recent …
Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight
MN Elshafei, NA Al-Khal, MFH Mohamed - 2022 - qspace.qu.edu.qa
Bodega et al.'s recent report on the efficacy and safety of direct oral anticoagulants (DOACs)
in patients with nonvalvular atrial fibrillation and extreme body weight reinforces recent …
in patients with nonvalvular atrial fibrillation and extreme body weight reinforces recent …